We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

BioAlliance Announces Phase I Trial for Fentanyl Lauriad® and the Submission of a Clonidine Lauriad® Phase II Clinical Trial Application

News   Oct 13, 2009

 
BioAlliance Announces Phase I Trial for Fentanyl Lauriad® and the Submission of a Clonidine Lauriad® Phase II Clinical Trial Application
 
 
 

RELATED ARTICLES

No Nose? No Problem! Scientists Discover That Plants Can Smell

News

Researchers have discovered the first steps of how information from odor molecules changes gene expression in plants. Manipulating plants' odor detection systems may lead to new ways of influencing plant behavior.

READ MORE

Temperature-stable Tuberculosis Vaccine Enters Clinical Testing

News

Vaccinations have begun in a Phase 1 human clinical trial testing a freeze-dried, temperature-stable formulation of an experimental tuberculosis vaccine candidate.

READ MORE

Genome Overlap in Human Mental Disorders and Canine Behavior

News

Researchers have identified two novel anxiety related genomic regions in German Shepherd dogs.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE